Shan Ahmed Khan

As a journalist focused on finance and the stock market, he delivers fast, reliable, and easy-to-understand coverage of market news.

Amicus Therapeutics (FOLD) Stock on Dec. 22, 2025: BioMarin’s $14.50 Buyout, Latest News, Analyst Forecasts, and What’s Next

Amicus Therapeutics (FOLD) Stock on Dec. 22, 2025: BioMarin’s $14.50 Buyout, Latest News, Analyst Forecasts, and What’s Next

Dec. 22, 2025 — Amicus Therapeutics, Inc. (NASDAQ: FOLD) has abruptly shifted from a “rare-disease growth story” into a deal-driven stock, after BioMarin Pharmaceutical announced an all-cash agreement to acquire Amicus for $14.50 per share. With shares trading around $14.18
AST SpaceMobile (ASTS) Stock in Focus: BlueBird-6 Launch Countdown, Fresh Valuation Debate, and Wall Street Targets (Dec. 22, 2025)

AST SpaceMobile (ASTS) Stock in Focus: BlueBird-6 Launch Countdown, Fresh Valuation Debate, and Wall Street Targets (Dec. 22, 2025)

AST SpaceMobile, Inc. (NASDAQ: ASTS) is back in the market’s spotlight on December 22, 2025, with investors zeroed in on one near-term catalyst: the launch of BlueBird 6, the company’s first next‑generation “Block 2” satellite. Today’s conversation around ASTS stock
Datavault AI (DVLT) Stock News Today: New Blockchain Patents, 2026 Revenue Forecasts, and the Catalysts Moving Shares (Dec. 22, 2025)

Datavault AI (DVLT) Stock News Today: New Blockchain Patents, 2026 Revenue Forecasts, and the Catalysts Moving Shares (Dec. 22, 2025)

Datavault AI Inc. (NASDAQ: DVLT) is back in the spotlight on December 22, 2025 after announcing two newly issued U.S. patents tied to blockchain-driven content licensing and tokenized monetization—an intellectual-property update that fits squarely into the company’s larger pitch: turning
1 290 291 292 293 294 599
Go toTop